<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>11</volume><submitter>Budama-Kilinc Y</submitter><pubmed_abstract>&lt;i>Onopordum acanthium&lt;/i> is a medicinal plant with many important properties, such as antibacterial, anticancer, and anti-hypotensive properties. Although various studies reported the biological activities of &lt;i>O. acanthium&lt;/i>, there is no study on its nano-phyto-drug formulation. The aim of this study is to develop a candidate nano-drug based on phytotherapeutic constituents and evaluate its efficiency &lt;i>in vitro&lt;/i> and &lt;i>in silico&lt;/i>. In this context, poly (lactic-co-glycolic acid) (PLGA) nanoparticles (NPs) of &lt;i>O. acanthium&lt;/i> extract (OAE) were synthesized and characterized. It was determined that the average particle size of OAE-PLGA-NPs was 214.9 ± 6.77 nm, and the zeta potential was -8.03 ± 0.85 mV, and PdI value was 0.064 ± 0.013. The encapsulation efficiency of OAE-PLGA</pubmed_abstract><journal>PeerJ</journal><pagination>e15523</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10257901</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>&lt;i>In vitro&lt;/i> and &lt;i>in silico&lt;/i> evaluation of the design of nano-phyto-drug candidate for oral use against &lt;i>Staphylococcus aureus&lt;/i>.</pubmed_title><pmcid>PMC10257901</pmcid><pubmed_authors>Budama-Kilinc Y</pubmed_authors><pubmed_authors>Cetin Aluc C</pubmed_authors><pubmed_authors>Gok B</pubmed_authors><pubmed_authors>Kecel-Gunduz S</pubmed_authors></additional><is_claimable>false</is_claimable><name>&lt;i>In vitro&lt;/i> and &lt;i>in silico&lt;/i> evaluation of the design of nano-phyto-drug candidate for oral use against &lt;i>Staphylococcus aureus&lt;/i>.</name><description>&lt;i>Onopordum acanthium&lt;/i> is a medicinal plant with many important properties, such as antibacterial, anticancer, and anti-hypotensive properties. Although various studies reported the biological activities of &lt;i>O. acanthium&lt;/i>, there is no study on its nano-phyto-drug formulation. The aim of this study is to develop a candidate nano-drug based on phytotherapeutic constituents and evaluate its efficiency &lt;i>in vitro&lt;/i> and &lt;i>in silico&lt;/i>. In this context, poly (lactic-co-glycolic acid) (PLGA) nanoparticles (NPs) of &lt;i>O. acanthium&lt;/i> extract (OAE) were synthesized and characterized. It was determined that the average particle size of OAE-PLGA-NPs was 214.9 ± 6.77 nm, and the zeta potential was -8.03 ± 0.85 mV, and PdI value was 0.064 ± 0.013. The encapsulation efficiency of OAE-PLGA</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023</publication><modification>2026-05-28T20:12:55.026Z</modification><creation>2024-11-19T23:17:25.162Z</creation></dates><accession>S-EPMC10257901</accession><cross_references><pubmed>37309371</pubmed><doi>10.7717/peerj.15523</doi></cross_references></HashMap>